This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nearly 40 million people in the United States suffer from migraine, with the World Health Organization classifying migraine as 1 of the 10 most disabling medical illnesses.
Did you know that insurance companies use middlemen — known as pharmacy benefit managers (PBMs) — to decide what medicines people can get and what people pay out of pocket for those medicines?
Matt Fitzgerald used to bike up and down 3,500 feet through the Santa Ana Mountains on three-hour rides just for fun. Now, nine months after being infected with SARS-CoV-2, the virus that causes Covid-19, he can’t muster walking on flat surfaces for 20 minutes without days of exhaustion. “My long Covid life remains terrifying,” he told me.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The founder of Mark Cuban Cost Plus Drug Company called drug pricing "insane" during a fireside chat at the Association of Accessible Medicines annual meeting.
Akin Akinc was scouring his email spam box last summer, looking for a missing message, when he stumbled across an unexpected email from a quite recognizable name: Feng Zhang. Zhang, one of the leading scientists in the groundbreaking field of genetic editing, had reached out two days prior to discuss a new company he was working on. Since helping to discover CRISPR-Cas9 — often referred to as molecular scissors that can cut into the genome and edit DNA — Zhang has founded at least
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The fudgy oat milk-based frozen dessert bars are available in four flavors — fudge n’ vanilla crunch, double chocolate fudge, fudge n’ caramel crunch and mint n’ fudge chip.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The European Commission (EC) has awarded IMPACTIVE almost €7.7 million to study the possibilities of mechanochemistry in the synthesis of active pharmaceutical ingredients (APIs). The ‘green’ project is a collaboration led by the University of Montpellier, in France. It is anticipated to reinvent and reinforce the pharmaceutical supply chain. The mechanochemistry initiative is funded by Horizon Europe and works with 17 partners in academia and industry working together towards greener chemistry.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
WASHINGTON — Congress’ efforts to get more information on the business practices of pharmacy benefit managers are running into an unlikely roadblock: Republicans’ dislike of Federal Trade Commission Chair Lina Khan and her approach to antitrust enforcement. The Senate Commerce Committee held a hearing Thursday on a bipartisan bill that aims to get the drug middlemen to tell the FTC how much money they make through pharmacy fees and “spread pricing,” a practice
The results of a cluster, RCT by UK researchers showed that a care home intervention involving independent pharmacist prescribers was unable to reduce the fall rate among residents over a six month period in comparison to a usual care, but had a significant impact on drug burden index. Older residents in a care home (CH) are recognised as being at a potentially higher risk of medication error and adverse drug reactions due to both polypharmacy and age-related alterations in drug pharmacokinetics
With hundreds of genes thought to be linked to obesity, the challenge is sifting through them all to determine which ones increase the risk of downstream complications like heart disease and diabetes. In a study published Thursday in Nature Genetics, researchers took the first steps in finding a potential candidate specifically in women.
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Lonza , a contract development and manufacturing organisation (CDMO), has announced that the planned expansion of its bioconjugation facility in Visp, Switzerland is complete. The expansion includes two manufacturing suites which will support companies entering clinical development. The investment will help support both clinical and commercial supply and be a key part in helping the company to meet the growing market demand for bioconjugates.
Good morning, and happy Thursday from STAT reporter Andrew Joseph, here filling in for Ed for the day. We’re up and at ‘em on this weirdly warm February day, thanks to today’s cup of stimulation, which promises notes of blueberry and toffee (we’re a light roast, whole milk kind of household). Subtle flavors aside, we’re more focused on the dangerously low levels of beans left in the grinder.
Is the pharmaceutical lobby on the ropes? What does it mean when a vaccine is “free”? And does biotech prepare you for the presidency? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Vas Narasimhan, CEO of Novartis and the new chairman of PhRMA, joins us to discuss the industry’s struggles in Washington and whether the deflated biotech sector is still overvalued.
If you’ve ever researched skin care products that can help reduce wrinkles and fine lines or improve acne, you might have stumbled upon a treatment called tretinoin. Tretinoin is a medication used on the skin that has been shown to aid in certain skin conditions and cosmetic goals. Keep reading to learn more about tretinoin, how it should be used, and safety precautions to keep in mind while using this medication.
The University of Texas MD Anderson Cancer Center has entered a strategic collaboration with biotech company Xilis for advancing new technology and expediting new cancer therapy development. The preclinical research deal will combine the MicroOrganoSphere (MOS) platform of Xilis with the expertise of MD Anderson for advancing new therapies development and cancer research.
Aspirin | Ibuprofen | Naproxen | Diclofenac | Best OTC anti-inflammatories | Side effects | Prescription vs. OTC anti-inflammatories If you experience minor aches and pains, an anti-inflammatory medicine may be the first thing you look for at the pharmacy. There are many different over-the-counter (OTC) drugs that can help relieve inflammation and pain, and they typically fall under the same class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs).
The probiotics industry contributes billions of dollars to the U.S. economy each year. With that being said, patients may look to purchase probiotics on their own accord or under the direction of their healthcare provider. Although they’re not usually regulated by the FDA and the guidelines for their use are relatively scarce, probiotics have been shown to have several health benefits.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content